Loading
Total declarations
Companies
▲ Purchases (16 ops.)
▼ Sales (5 ops.)
Latest filing published 10 Aug 2026 for Latigo Biotherapeutics, Inc.. Read the official filing
Filing timeline
BuySaleBeth C. Seidenberg
Insider track record
Disclosed buys
16
Disclosed sells
5
T+90 hit rate
75%
T+90 mean return
+65.3%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Beth C. Seidenberg: trading record in brief
Beth C. Seidenberg is a declared insider at 10 companies (board member); the most frequent names are Progyny, Inc., TESARO, Inc. and Vera Therapeutics, Inc. Between 16 December 2015 and 10 August 2026, the trades on record add up to 92 filings.
On the open market, the record shows 16 purchases worth €47.5M and 5 sales worth €3.1M. Purchases outweigh sales by €44.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 19 share grants.
The median purchase comes to €189k. Clusters matter here: 9 out of 16 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 10 August 2026 came the latest disclosure, a transaction in Latigo Biotherapeutics, Inc. The last insider purchase was made public on 22 December 2025, 303 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Beth C. Seidenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
938,979 sharesCommon StockSEC:0001184592-26-000005:0
3,547,842 sharesCommon StockSEC:0001184592-26-000005:1
1,027,635 sharesCommon StockSEC:0001184592-26-000005:2
3,464,072 sharesCommon StockSEC:0001184592-26-000005:3
1,484,401 sharesCommon StockSEC:0001184592-26-000005:4
165,519 sharesCommon StockSEC:0001184592-26-000005:5
2,066,857 sharesCommon StockSEC:0001184592-26-000005:6
133,333 shares@ US$7.50100.0% of flowCommon StockSEC:0001104659-25-123597:0
Canonical exit: 18 Mar 2026 (T+90)
16,634 shares0Common StockSEC:0000950170-25-080457:0
60,000 sharesCommon StockSEC:0001962918-25-000062:0
14,798 shares@ US$48.012328.4% of flowClass A Common StockSEC:0001415889-24-025746:0
1,177 shares@ US$42.01191.9% of flowClass A Common StockSEC:0001415889-24-023779:0
7,206 shares0Common StockSEC:0001551306-24-000122:0
3,787,940 sharesCommon StockSEC:0000950170-24-015465:0
38,763 sharesCommon StockSEC:0001104659-23-082736:0
17,162 shares0Common StockSEC:0001628280-23-023606:0
1,398,900 shares0Common StockSEC:0001628280-23-022017:0
57,000 shares0Common StockSEC:0001140361-23-028161:0
5,116 shares0Common StockSEC:0001628280-23-020505:0
8,540,729 sharesCommon StockSEC:0001209191-23-028884:0
2,300 shares@ US$7.23950.7% of flowClass A Common StockSEC:0001209191-23-022150:0
Canonical exit: 28 Jun 2023 (T+90)
23,908 shares@ US$7.24416.9% of flowClass A Common StockSEC:0001209191-23-021609:0
Canonical exit: 26 Jun 2023 (T+90)
1,833 shares@ US$7.24050.5% of flowClass A Common StockSEC:0001209191-23-021386:0
Canonical exit: 22 Jun 2023 (T+90)
74,045 shares@ US$7.115721.4% of flowClass A Common StockSEC:0001209191-23-020280:0
Canonical exit: 15 Jun 2023 (T+90)
32,844 shares@ US$7.12499.4% of flowClass A Common StockSEC:0001209191-23-019611:0
Canonical exit: 13 Jun 2023 (T+90)
25 of 41 declarations
